vs
HF Foods Group Inc.（HFFG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
HF Foods Group Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.5倍（$308.0M vs $207.3M），HF Foods Group Inc.净利率更高（-12.1% vs -62.0%，领先49.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 0.9%），HF Foods Group Inc.自由现金流更多（$12.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 2.1%）
HF Sinclair Corporation是一家总部位于美国得克萨斯州达拉斯的美国能源企业，主要生产并销售汽油、柴油、航空燃油、可再生柴油、特种润滑油产品、特种化学品，以及特种改性沥青等多种能源与化工产品。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
HFFG vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $308.0M | $207.3M |
| 净利润 | $-37.3M | $-128.6M |
| 毛利率 | 16.6% | — |
| 营业利润率 | -12.8% | -54.7% |
| 净利率 | -12.1% | -62.0% |
| 营收同比 | 0.9% | 25.9% |
| 净利润同比 | 15.0% | 3.5% |
| 每股收益（稀释后） | $-0.70 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $308.0M | $207.3M | ||
| Q3 25 | $307.0M | $159.9M | ||
| Q2 25 | $314.9M | $166.5M | ||
| Q1 25 | $298.4M | $139.3M | ||
| Q4 24 | $305.3M | $164.6M | ||
| Q3 24 | $298.4M | $139.5M | ||
| Q2 24 | $302.3M | $147.0M | ||
| Q1 24 | $295.7M | $108.8M |
| Q4 25 | $-37.3M | $-128.6M | ||
| Q3 25 | $-1.1M | $-180.4M | ||
| Q2 25 | $1.2M | $-115.0M | ||
| Q1 25 | $-1.6M | $-151.1M | ||
| Q4 24 | $-43.9M | $-133.2M | ||
| Q3 24 | $-3.9M | $-133.5M | ||
| Q2 24 | $17.0K | $-131.6M | ||
| Q1 24 | $-694.0K | $-170.7M |
| Q4 25 | 16.6% | — | ||
| Q3 25 | 16.4% | — | ||
| Q2 25 | 17.5% | — | ||
| Q1 25 | 17.1% | — | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 17.4% | — | ||
| Q1 24 | 17.1% | — |
| Q4 25 | -12.8% | -54.7% | ||
| Q3 25 | 0.4% | -106.9% | ||
| Q2 25 | 1.3% | -64.8% | ||
| Q1 25 | 0.4% | -102.6% | ||
| Q4 24 | -13.8% | -74.3% | ||
| Q3 24 | 0.2% | -94.6% | ||
| Q2 24 | 0.9% | -79.1% | ||
| Q1 24 | -0.0% | -151.9% |
| Q4 25 | -12.1% | -62.0% | ||
| Q3 25 | -0.4% | -112.8% | ||
| Q2 25 | 0.4% | -69.0% | ||
| Q1 25 | -0.6% | -108.5% | ||
| Q4 24 | -14.4% | -80.9% | ||
| Q3 24 | -1.3% | -95.7% | ||
| Q2 24 | 0.0% | -89.5% | ||
| Q1 24 | -0.2% | -156.8% |
| Q4 25 | $-0.70 | $-1.28 | ||
| Q3 25 | $-0.02 | $-1.81 | ||
| Q2 25 | $0.02 | $-1.17 | ||
| Q1 25 | $-0.03 | $-1.57 | ||
| Q4 24 | $-0.84 | $-1.34 | ||
| Q3 24 | $-0.07 | $-1.40 | ||
| Q2 24 | $0.00 | $-1.52 | ||
| Q1 24 | $-0.01 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | $106.1M | — |
| 股东权益账面价值 | $202.1M | $-80.0M |
| 总资产 | $541.5M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.53× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M | ||
| Q1 24 | — | $112.3M |
| Q4 25 | $106.1M | — | ||
| Q3 25 | $107.3M | — | ||
| Q2 25 | $106.0M | — | ||
| Q1 25 | $107.4M | — | ||
| Q4 24 | $108.7M | — | ||
| Q3 24 | $110.1M | — | ||
| Q2 24 | $111.4M | — | ||
| Q1 24 | $112.8M | — |
| Q4 25 | $202.1M | $-80.0M | ||
| Q3 25 | $239.2M | $9.2M | ||
| Q2 25 | $239.7M | $151.3M | ||
| Q1 25 | $238.0M | $144.2M | ||
| Q4 24 | $239.3M | $255.0M | ||
| Q3 24 | $283.1M | $346.8M | ||
| Q2 24 | $286.3M | $432.4M | ||
| Q1 24 | $286.7M | $140.3M |
| Q4 25 | $541.5M | $1.5B | ||
| Q3 25 | $595.1M | $1.2B | ||
| Q2 25 | $593.5M | $1.3B | ||
| Q1 25 | $581.9M | $1.3B | ||
| Q4 24 | $550.0M | $1.5B | ||
| Q3 24 | $612.8M | $1.5B | ||
| Q2 24 | $616.9M | $1.6B | ||
| Q1 24 | $603.1M | $1.3B |
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.39× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $12.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 3.9% | -48.6% |
| 资本支出强度资本支出/营收 | 2.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $21.0M | $-99.8M | ||
| Q3 25 | $-6.0M | $-91.4M | ||
| Q2 25 | $3.5M | $-108.3M | ||
| Q1 25 | $6.9M | $-166.5M | ||
| Q4 24 | $18.4M | $-79.3M | ||
| Q3 24 | $2.3M | $-67.0M | ||
| Q2 24 | $-9.3M | $-77.0M | ||
| Q1 24 | $11.2M | $-190.7M |
| Q4 25 | $12.1M | $-100.8M | ||
| Q3 25 | $-9.3M | $-92.7M | ||
| Q2 25 | $363.0K | $-110.7M | ||
| Q1 25 | $3.4M | $-167.8M | ||
| Q4 24 | $15.3M | $-79.5M | ||
| Q3 24 | $-820.0K | $-68.6M | ||
| Q2 24 | $-13.0M | $-79.0M | ||
| Q1 24 | $8.6M | $-193.9M |
| Q4 25 | 3.9% | -48.6% | ||
| Q3 25 | -3.0% | -58.0% | ||
| Q2 25 | 0.1% | -66.5% | ||
| Q1 25 | 1.1% | -120.5% | ||
| Q4 24 | 5.0% | -48.3% | ||
| Q3 24 | -0.3% | -49.2% | ||
| Q2 24 | -4.3% | -53.7% | ||
| Q1 24 | 2.9% | -178.2% |
| Q4 25 | 2.9% | 0.5% | ||
| Q3 25 | 1.1% | 0.8% | ||
| Q2 25 | 1.0% | 1.5% | ||
| Q1 25 | 1.2% | 1.0% | ||
| Q4 24 | 1.0% | 0.1% | ||
| Q3 24 | 1.0% | 1.2% | ||
| Q2 24 | 1.2% | 1.4% | ||
| Q1 24 | 0.9% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.89× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -546.06× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HFFG
| Seafood | $110.2M | 36% |
| Meat And Poultry | $62.7M | 20% |
| Asian Specialty | $55.3M | 18% |
| Commodity Product | $35.1M | 11% |
| Fresh Produce | $29.9M | 10% |
| Packaging And Other | $14.7M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
